Chowdhury Debashish, Datta Debabrata, Mundra Ankit, Duggal Ashish, Krishnan Anand
Department of Neurology, GB Pant Institute of Post Graduate Medical Education and Research, New Delhi.
Department of Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
Ann Indian Acad Neurol. 2024 May 1;27(3):254-263. doi: 10.4103/aian.aian_40_24. Epub 2024 May 17.
To assess attention, vigilance, and executive functions in migraine patients during headache-free (interictal) periods and in healthy controls without migraine and to study the impact of migraine preventive treatment on these cognitive functions.
Preventive drug-naive migraine patients, aged ≥18 years, without a history of medication overuse were studied and compared to non-migraine controls. Psychiatric comorbidity was screened by Patient Health Questionnaire-9, and those who screened positive were evaluated further by specific scales. The Epworth Sleepiness Scale assessed subjective complaints of sleep quality. Cognitive functions were assessed by Mini-Mental State Examination (MMSE), digit span forward and backward (DS-F, DS-B), trail-making tests (TMT-A and B) and Stroop word (SW), Stroop color (SC), and Stroop interference (SI) tests. Cognitive test scores at the end of 6 months following treatment were compared to baseline scores.
One hundred and fifty migraine patients and controls each were studied. Compared to controls, migraine patients performed significantly worse in DS-B ( P < 0.0001), TMT-A ( P = 0.00004), TMT-B ( P < 0.0001), SW ( P < 0.0001), SC ( P < 0.0001), and SI ( P = 0.0221). MMSE scores did not differ between patients and the controls ( P = 0.3224). Compared to the patients without psychiatric comorbidity, migraine patients with psychiatric comorbidity showed no significant differences in the cognitive test scores. Significant improvement in all cognitive test scores ( P < 0.001) was observed after 6 months of treatment.
Migraine patients, compared to non-migraine controls, showed deficits in attention, vigilance, and executive functions during the interictal period, which improved with successful preventive treatment. Psychiatric comorbidities did not have a significant impact on cognitive dysfunctions.
评估偏头痛患者在无头痛(发作间期)期间以及无偏头痛的健康对照者的注意力、警觉性和执行功能,并研究偏头痛预防性治疗对这些认知功能的影响。
研究年龄≥18岁、无药物过度使用史且未接受过预防性药物治疗的偏头痛患者,并与非偏头痛对照者进行比较。通过患者健康问卷-9筛查精神共病,筛查呈阳性者进一步用特定量表进行评估。爱泼华嗜睡量表评估睡眠质量的主观主诉。认知功能通过简易精神状态检查表(MMSE)、顺背和倒背数字广度(DS-F、DS-B)、连线测验(TMT-A和B)以及Stroop文字(SW)、Stroop颜色(SC)和Stroop干扰(SI)测验进行评估。将治疗6个月后的认知测试分数与基线分数进行比较。
共研究了150名偏头痛患者和150名对照者。与对照者相比,偏头痛患者在DS-B(P<0.0001)、TMT-A(P=0.00004)、TMT-B(P<0.0001)、SW(P<0.0001)、SC(P<0.0001)和SI(P=0.0221)方面表现明显更差。患者和对照者的MMSE分数无差异(P=0.3224)。与无精神共病的患者相比,有精神共病的偏头痛患者在认知测试分数上无显著差异。治疗6个月后,所有认知测试分数均有显著改善(P<0.001)。
与非偏头痛对照者相比,偏头痛患者在发作间期存在注意力、警觉性和执行功能缺陷,成功的预防性治疗可使其改善。精神共病对认知功能障碍无显著影响。